Related Experiment Video

Updated: Oct 9, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1

Y Le1, W Gong, H L Tiffany

  • 1Laboratory of Molecular Immunoregulation, Division of Basic Sciences, International Corporation Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|February 13, 2001
PubMed

Insights

Alzheimer's disease involves amyloid beta (Abeta). This study reveals Abeta(42) activates FPR-Like-1 (FPRL1) on immune cells, suggesting FPRL1 as a therapeutic target for AD-related inflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Amyloid beta (Abeta) is implicated in Alzheimer's disease (AD) pathogenesis.
  • Abeta causes neurotoxicity directly and indirectly via immune cell activation.
  • Microglia activation and accumulation in senile plaques contribute to neuronal damage.

Purpose of the Study:

  • To investigate the interaction between Abeta and mononuclear phagocytes.
  • To identify receptors mediating Abeta-induced inflammation in AD.
  • To explore potential therapeutic targets for Alzheimer's disease.

Main Methods:

  • Characterization of Abeta(42) as a ligand.
  • Analysis of FPR-Like-1 (FPRL1) expression on human mononuclear phagocytes.
  • Examination of FPRL1 expression in brain tissues from AD patients.

Main Results:

  • Abeta(42) functions as a chemotactic agonist for FPRL1.
  • FPRL1 is expressed on human mononuclear phagocytes.
  • High levels of FPRL1 are found on inflammatory cells within senile plaques in AD brains.

Conclusions:

  • FPRL1 mediates Abeta-induced inflammation in Alzheimer's disease.
  • FPRL1 is a potential therapeutic target for AD.
  • Targeting FPRL1 may offer a novel strategy for treating AD-related neuroinflammation.

More Related Videos

A Caenorhabditis elegans Model System for Amylopathy Study10:33

A Caenorhabditis elegans Model System for Amylopathy Study

Published on: May 17, 2013

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Related Concept Videos

Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
G Protein-coupled Receptors01:27

G Protein-coupled Receptors

G-protein-coupled receptors are ligand-binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that traverses the cell membrane seven times, creating intracellular and extracellular loops. The extracellular loops create a ligand-specific pocket which binds to neurotransmitters or hormones. The intracellular loops hold onto the G-protein.The G-protein, or guanine nucleotide-binding protein, is a large heterotrimeric complex. Its three subunits...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...